Laryngeal Cancer

Our specialists are experts in diagnosing and treating laryngeal cancer. We build a care plan that is tailored for your needs and delivered with compassion. Our head and neck surgeons specialize in minimally invasive surgery to remove laryngeal cancer and are leaders in reconstructive surgical techniques. Throughout your treatment and recovery, we offer support services such as therapy to help maintain or restore your speech and ability to swallow.

Clinical Trials and Research Studies

Phase 5

A Phase 1/2a Multi-Center Open-Label Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Evidence of Antitumor Activity of JAB-3312 in combination with pembrolizumab or binimetinib in Adult Patients with Advanced Solid Tumors

Learn More

Phase 1

An Open Label First in Human (FIH) Phase 1 Trial of LVGN6051 as Single Agent and in Combination with Keytruda (pembrolizumab) in Advanced or Metastatic Malignancy

Learn More

Phase 5

A PHASE 1/2 OPEN-LABEL DOSE-ESCALATION SAFETY AND TOLERABILITY STUDY OF NC410 IN SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS

Learn More

Phase 3

A randomized double-blind placebo-controlled Phase 3 study of Debio 1143 in combo w/ platinum-based chemo & standard fractionation intensitymodulated radiotherapy in patients w/ locally advanced HNSCC suitable for definitive chemoradiotherapy

Learn More